Search results
YOUR HEALTH: New hope for Non-Hodgkin’s Lymphoma patients
WAFB Baton Rouge· 7 days agoNon-Hodgkin’s lymphoma, or NHL, is one of the most common cancers – one in 43 men and one in 53...
...Administration Approves Bristol Myers Squibb’s Breyanzi as a New CAR T Cell Therapy...for...
Morningstar· 5 days agoU.S. Food and Drug Administration Approves Bristol Myers Squibb’s Breyanzi as a New CAR T Cell Therapy for Relapsed or Refractory Mantle Cell Lymphoma ...
Cancer can take away a lot, but for one man in Pine Mountain club, it has given him creativity
KERO 23 Bakersfield· 6 days agoBuddy Morsello shares how his battle with stage four Non Hodgkin's Lymphoma gave him the inspiration...
Bristol Myers Squibb’s Breyanzi gains FDA approval for lymphoma
Pharmaceutical Technology via Yahoo Finance· 4 days agoAdministered as a one-time infusion, the cell therapy’s single dose contains 90 to 110 x 10^6...
Triplet Notches Survival Win in Heavily Pretreated DLBCL
MedPage Today· 2 days agoBenefit with BV plus lenalidomide-rituximab seen in those who relapsed after CAR-T or transplant
Takeda and Pfizer report positive Phase III HD21 trial of ADCETRIS
Clinical Trials Arena via Yahoo Finance· 1 day agoThe study met its co-primary endpoints at a preplanned three-year analysis, showing significantly...
Nurix Therapeutics enhances leadership team By Investing.com
Investing.com· 7 days ago(NASDAQ:NRIX), a biopharmaceutical company specializing in cancer and inflammatory diseases ...
Subaru Partners With the Leukemia & Lymphoma Society for Ninth Year Supporting Patients Facing...
Morningstar· 20 hours agoCAMDEN, NJ / ACCESSWIRE / June 3, 2024 / Subaru of America, Inc. today announced the ninth consecutive year of partnering with The Leukemia & Lymphoma Society (LLS) during ...
Democratic Rep Sheila Jackson Lee reveals cancer diagnosis
The Independent via Yahoo News· 1 day agoThe 74-year-old congresswoman lost out to Democratic state Senator...In late 2022, congressman Jamie...
Why Is Bristol Myers Squibb Stock Trading Higher On Friday? - Bristol-Myers Squibb (NYSE:BMY)
Benzinga· 4 days agoThis FDA approval marks the fourth distinct subtype of non-Hodgkin lymphoma for which Breyanzi is...